# Targeting the Right Ventricle in Pulmonary Hypertension

> **NCT01839110** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 22 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01839110
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839110, "Targeting the Right Ventricle in Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01839110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*